Target intelligence / Profile preview

Glycine receptor subunit alpha-2 (GLRA2)

Target
GLRA2
Molecular classification
Ligand-gated ion channel, Ion channel, Receptor, Cys-loop receptor family
01

Overview

Glycine receptor subunit alpha-2 (GLRA2) is a protein component of the glycine receptor, which is a pentameric ligand-gated chloride ion channel primarily found in the central nervous system, especially during embryonic and early postnatal development[1][2][3][4]. This receptor mediates inhibitory neurotransmission by allowing chloride influx upon activation by glycine, leading to neuronal hyperpolarization and reduced excitability[1][3][4]. The alpha-2 subunit is especially prominent in the developing cortex and participates in critical processes such as cortical interneuron migration, progenitor homeostasis, and modulation of neuronal circuitry[2][3]. Mutations or deletions in GLRA2 are linked to neurodevelopmental disorders, including intellectual disability, autism spectrum disorder, epilepsy, and microcephaly[1][2][3]. Strychnine is a potent competitive antagonist of glycine receptors containing the alpha-2 subunit, while ethanol also modulates receptor function[1][3]. Disruption of GLRA2 function, either via genetic mutation or pharmacological inhibition, compromises inhibitory signaling, potentially resulting in abnormal brain development or increased susceptibility to seizures[2][3].

Other names
Glycine receptor alpha 2GLRA2GLRMRXSPglycine receptor alpha 2 subunitglycine receptor, alpha-2 polypeptide
02

Mechanism of action

Modulation or inhibition of chloride ion conductance through receptor antagonism or allosteric modulation (e.g., strychnine blocks the glycine-activated ion channel, leading to increased neuronal excitability)

03

Biological functions

Inhibitory neurotransmissionSynaptic plasticityNeuronal excitability regulationCortical interneuron migrationNeurodevelopment (progenitor homeostasis, neuronal differentiation)Regulation of motor and sensory pathways
04

Disease associations

Neurodevelopmental disorders (e.g., intellectual developmental disorder, developmental delay)Autism spectrum disorderEpilepsyMicrocephaly
05

Safety considerations

Potential for neurotoxicity or seizure propensity when function is disrupted (by mutation or pharmacological block)Possible developmental abnormalities if antagonized or genetically mutated
06

Interacting drugs

Strychnine (antagonist)

2 more in the full profile.

Beyond the preview

Go deeper on Glycine receptor subunit alpha-2 (GLRA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glycine receptor subunit alpha-2 (GLRA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call